PSIP1 and Alzheimer disease: The low prevalence of anti-DFS70 antibodies in patients with SARD is interesting and represents a potentially important biomarker that can be clinically used to discriminate SARD from ANA-positive HI and/or other inflammatory conditions such as AD.